D
ArriVent BioPharma, Inc. AVBP
$34.00 $0.180.52% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2026 12/31/2025 09/30/2025 06/30/2025 03/31/2025
Total Cash And Short-Term Investments 4.33% 4.18% 27.40% 33.85% -19.55%
Total Receivables -- -- 0.00% 0.00% 1.00%
Inventory -- -- -- -- --
Prepaid Expenses 669.89% -66.30% -29.86% -35.76% 200.98%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets 5.02% -0.03% 51.06% 65.08% 10.67%
Total Current Assets 4.75% 3.64% 28.41% 34.64% -18.15%

Total Current Assets 4.75% 3.64% 28.41% 34.64% -18.15%
Net Property, Plant & Equipment 2,746.15% -73.47% -42.35% -29.17% -22.08%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -13.13% 43.89% -62.42% 172.16% 39.68%
Total Assets 4.84% 2.03% 21.17% 25.06% -21.62%

Total Accounts Payable 47.07% 0.02% 46.13% -6.97% 15.39%
Total Accrued Expenses -19.14% 28.44% 0.59% 83.15% -36.60%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current 607.14% -75.00% -42.86% -28.99% -14.81%
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities -3.66% 20.35% 9.79% 51.59% -25.01%

Total Current Liabilities -3.66% 20.35% 9.79% 51.59% -25.01%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities -2.43% 20.35% 9.79% 51.59% -25.08%

Common Stock & APIC 8.48% 5.63% 15.39% 15.58% 1.83%
Retained Earnings -10.71% -9.63% -10.47% -10.37% -27.02%
Treasury Stock & Other -2,028.57% -93.20% 1,244.44% -5.88% 91.94%
Total Common Equity 5.45% 0.73% 22.06% 23.37% -21.39%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 5.45% 0.73% 22.06% 23.37% -21.39%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 5.45% 0.73% 22.06% 23.37% -21.39%